We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

200 hedge funds and large institutions have $1.36B invested in Dynavax Technologies in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 25

19% more call options, than puts

Call options by funds: $24.7M | Put options by funds: $20.8M

9% more funds holding

Funds holding: 183200 (+17)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

3% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 60

4.11% less ownership

Funds ownership: 84.46%80.35% (-4.1%)

27% less capital invested

Capital invested by funds: $1.86B → $1.36B (-$502M)

Holders
200
Holders Change
+17
Holders Change %
+9.29%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
42
Increased
58
Reduced
60
Closed
25
Calls
$24.7M
Puts
$20.8M
Net Calls
+$3.89M
Net Calls Change
-$26M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$228M +$14.4M +874,438 +6%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$118M
BlackRock
3
BlackRock
New York
$111M -$1.11M -67,483 -0.9%
State Street
4
State Street
Massachusetts
$87.9M +$17M +1,031,099 +20%
Vanguard Group
5
Vanguard Group
Pennsylvania
$83.1M +$4.67M +283,799 +5%
CC
6
Chicago Capital
Illinois
$80.7M +$218K +13,278 +0.2%
PHS
7
PFM Health Sciences
California
$53.5M +$8.59M +521,800 +16%
Fisher Asset Management
8
Fisher Asset Management
Washington
$50.7M +$4.64M +282,002 +8%
William Blair & Company
9
William Blair & Company
Illinois
$31.6M -$138K -8,399 -0.4%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$29.3M +$924K +56,165 +3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$26.9M +$1.67M +101,297 +6%
Goldman Sachs
12
Goldman Sachs
New York
$25.9M +$12.3M +747,533 +69%
Millennium Management
13
Millennium Management
New York
$24.9M +$23.2M +1,412,111 +394%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$24.1M -$5.32M -323,200 -16%
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$23M +$21.6M +1,310,560 +423%
RSCM
16
Rock Springs Capital Management
Maryland
$22.2M +$2.42M +146,973 +10%
Morgan Stanley
17
Morgan Stanley
New York
$20.1M -$7.36M -447,027 -24%
N
18
Nuveen
North Carolina
$19.3M +$5.5M +334,050 +32%
Northern Trust
19
Northern Trust
Illinois
$17M -$208K -12,647 -1%
Two Sigma Investments
20
Two Sigma Investments
New York
$14.3M -$17.6M -1,072,359 -51%
Charles Schwab
21
Charles Schwab
California
$12.1M +$1.12M +67,923 +9%
Marshall Wace
22
Marshall Wace
United Kingdom
$12M -$70.2M -4,264,961 -83%
Macquarie Group
23
Macquarie Group
Australia
$10.7M
RPAM
24
Rhenman & Partners Asset Management
Sweden
$10.7M
Norges Bank
25
Norges Bank
Norway
$10.6M +$5.13M +311,700 +71%

DVAX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q4 2021, worth a combined $1.36B — down 27% from $1.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new DVAX positions and 25 closed out — a net gain of 17 holders — while 58 added to existing stakes and 60 trimmed.

The largest buyer was Millennium Management, adding an estimated $23.2M. The largest seller was Marshall Wace, cutting an estimated $70.2M.

  • 200 institutional investors held Dynavax Technologies (DVAX) as of Q4 2021, up from 183 in Q3 2021.
  • Funds reported $1.36B of Dynavax Technologies stock for Q4 2021, down 27% quarter-over-quarter.
  • 42 funds opened new Dynavax Technologies positions in Q4 2021 and 25 closed out, a net change of +17 holders.
  • The largest Dynavax Technologies buyer in Q4 2021 was Millennium Management, an estimated $23.2M added.
  • The largest Dynavax Technologies seller in Q4 2021 was Marshall Wace, an estimated $70.2M sold.

Based on aggregated 13F filings for Q4 2021.